BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21682141)

  • 1. A molecular docking study of anticancer drug paclitaxel and its analogues.
    Sinha R; Vidyarthi AS; Shankaracharya
    Indian J Biochem Biophys; 2011 Apr; 48(2):101-5. PubMed ID: 21682141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77.
    Ferlini C; Cicchillitti L; Raspaglio G; Bartollino S; Cimitan S; Bertucci C; Mozzetti S; Gallo D; Persico M; Fattorusso C; Campiani G; Scambia G
    Cancer Res; 2009 Sep; 69(17):6906-14. PubMed ID: 19671798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rational design of bioactive taxanes with side chains situated elsewhere than on C-13.
    Wu JH; Zamir LO
    Anticancer Drug Des; 2000 Feb; 15(1):73-8. PubMed ID: 10888038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for the interaction of paclitaxel with the Bcl-2 loop domain: a chemical approach to induce conformation-dependent phosphorylation.
    Wu JH; Batist G; Zamir LO
    Anticancer Drug Des; 2000 Dec; 15(6):441-6. PubMed ID: 11716437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY".
    Yang Y; Alcaraz AA; Snyder JP
    J Nat Prod; 2009 Mar; 72(3):422-9. PubMed ID: 19267457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interaction of Bcl-2 proteins with tubulin.
    Knipling L; Wolff J
    Biochem Biophys Res Commun; 2006 Mar; 341(2):433-9. PubMed ID: 16446153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insight into the mechanism of epothilone A bound to beta-tubulin and its mutants at Arg282Gln and Thr274Ile.
    Shi G; Wang Y; Jin Y; Chi S; Shi Q; Ge M; Wang S; Zhang X; Xu S
    J Biomol Struct Dyn; 2012; 30(5):559-73. PubMed ID: 22731768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the environment of tubulin-bound paclitaxel using fluorescent paclitaxel analogues.
    Sengupta S; Boge TC; Liu Y; Hepperle M; Georg GI; Himes RH
    Biochemistry; 1997 Apr; 36(17):5179-84. PubMed ID: 9136879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
    Blagosklonny MV; Giannakakou P; el-Deiry WS; Kingston DG; Higgs PI; Neckers L; Fojo T
    Cancer Res; 1997 Jan; 57(1):130-5. PubMed ID: 8988053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence divergence of Entamoeba histolytica tubulin is responsible for its altered tertiary structure.
    Roy D; Lohia A
    Biochem Biophys Res Commun; 2004 Jul; 319(3):1010-6. PubMed ID: 15184082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-Taxol and the electron crystallographic density in beta-tubulin.
    Johnson SA; Alcaraz AA; Snyder JP
    Org Lett; 2005 Dec; 7(25):5549-52. PubMed ID: 16320988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization and molecular dynamic simulation of β-sitosterol as a tubulin-binding anticancer agent.
    Mahaddalkar T; Suri C; Naik PK; Lopus M
    Eur J Pharmacol; 2015 Aug; 760():154-62. PubMed ID: 25912799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of an intermediate taxol binding site within microtubule nanopores and a mechanism for tubulin isotype binding selectivity.
    Freedman H; Huzil JT; Luchko T; Ludueña RF; Tuszynski JA
    J Chem Inf Model; 2009 Feb; 49(2):424-36. PubMed ID: 19434843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.
    Snyder JP; Nettles JH; Cornett B; Downing KH; Nogales E
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5312-6. PubMed ID: 11309480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of bax in apoptosis depends on microtubule network mobility.
    Longuet M; Serduc R; Riva C
    Int J Oncol; 2004 Aug; 25(2):309-17. PubMed ID: 15254727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
    Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
    Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel binding to the fatty acid-induced conformation of human serum albumin--automated docking studies.
    Paal K; Shkarupin A
    Bioorg Med Chem; 2007 Dec; 15(24):7568-75. PubMed ID: 17892938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies.
    Magnani M; Ortuso F; Soro S; Alcaro S; Tramontano A; Botta M
    FEBS J; 2006 Jul; 273(14):3301-10. PubMed ID: 16803461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel macrocyclic docetaxel analogues. Influence of their macrocyclic ring size on tubulin activity.
    Querolle O; Dubois J; Thoret S; Roussi F; Montiel-Smith S; Guéritte F; Guénard D
    J Med Chem; 2003 Aug; 46(17):3623-30. PubMed ID: 12904066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.
    Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF
    Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.